Please use this identifier to cite or link to this item:
https://repository.iimb.ac.in/handle/2074/13735
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chatterjee, Chirantan | - |
dc.date.accessioned | 2020-08-11T14:59:10Z | - |
dc.date.available | 2020-08-11T14:59:10Z | - |
dc.date.issued | 2011 | - |
dc.identifier.uri | https://repository.iimb.ac.in/handle/2074/13735 | - |
dc.language.iso | en_US | - |
dc.publisher | IndiaBioscience | - |
dc.subject | Pharmaceutical industry | - |
dc.subject | Policy making | - |
dc.subject | Pharmaceutical policy | - |
dc.title | It’s time for De-Novo thinking in Indian pharmaceutical policy making | - |
dc.type | Blog Article | - |
dc.identifier.url | http://www.indiabioscience.org/ | - |
Appears in Collections: | 2010-2019 |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.